Twitter Acquires Scroll

Twitter Inc. (TWTR) Tuesday announced it has acquired Scroll, a subscription platform for users who don't want to read content with ads or pop ups, but still support publishers to bring in more revenue than with traditional ads on a page. This acquisition is part of Twitter's plan to build its own subscription service.

"This is an exciting opportunity for us to introduce this proven model to publishers on our service and make reading the news better for everyone involved. Looking ahead, Scroll will become a meaningful addition to our subscriptions work as we build and shape a future subscription service on Twitter," said Mike Park, VP, Product, in a statement.

Going forward, Twitter plans to include Scroll as part of an upcoming subscription offering that the social media giant is currently exploring.

"As a Twitter subscriber, picture getting access to premium features where you can easily read articles from your favorite news outlet or a writer's newsletter from Revue, with a portion of your subscription going to the publishers and writers creating the content," Park added.

In January, Twitter announced it had acquired Revue, a service to help people to publish newsletters on social media. On Monday, Twitter launched its Spaces feature for anyone with at least 600 followers.

Meanwhile, Scroll will temporarily pause new sign-ups. Following the acquisition, Twitter will be working to include Scroll's product into its subscription plans and prepare to grow Scroll's publisher network.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The 737 MAX 10, Boeing Co.'s largest 737 Max model, is taking its maiden flight today, reports said citing people familiar with the matter. The flight after months of testing and certification will be around 10 a.m. local time from the Seattle area. The schedule could change depending on weather or other factors. Meanwhile, the jetliner is expected to enter commercial service in 2023. Medical devices supplier Smiths Medical, affiliated to Smiths Group plc, is recalling certain Jelco Hypodermic Needle-Pro Fixed Needle insulin syringes with skewed graduation markings, the U.S. Food and Drug Administration said. The recall was initiated after the company became aware of specific models and lots of Jelco insulin syringes that may exhibit skewed odd number line graduation markings. Saliva-based COVID-19 testing is rolled out as a pilot for public schools in New York City. The new two-month pilot program is being implemented in about 50 New York City public schools and utilizes Fluidigm Technology to offer RT-PCR COVID-19 testing. New York City public schools have instituted mandatory random weekly testing in all reopened school buildings to ensure safer in-person learning.
Follow RTT